QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 166 filers reported holding QIAGEN NV in Q1 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $45,000 | 0.0% | 1,800 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $45,000 | +7.1% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $42,000 | +2.4% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $41,000 | -16.3% | 1,800 | -10.0% | 0.00% | -50.0% |
| Q2 2014 | $49,000 | +16.7% | 2,000 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $42,000 | -30.0% | 2,000 | -20.0% | 0.00% | -50.0% |
| Q4 2013 | $60,000 | +11.1% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $54,000 | -51.4% | 2,500 | -58.3% | 0.00% | -33.3% |
| Q3 2012 | $111,000 | +11.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $100,000 | -20.0% | 6,000 | -25.0% | 0.00% | 0.0% |
| Q1 2012 | $125,000 | +13.6% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q4 2011 | $110,000 | -0.9% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $111,000 | -27.0% | 8,000 | 0.0% | 0.00% | -25.0% |
| Q2 2011 | $152,000 | -5.0% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q1 2011 | $160,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
| Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
| Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
| Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
| HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
| CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
| GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
| Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
| PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |